# Tobira Therapeutics, Inc.

Tobira Therapeutics, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Tobira Therapeutics, Inc.
- **Former names in filing history:** Tibira Therapeutics, Inc. (2015-05-06 to 2015-05-06); Regado Biosciences Inc (2004-12-08 to 2015-05-06)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001311596

## About

Tobira Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001311596, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-03, it reported net income of USD -49,617,000; total assets of USD 65,469,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Net income:** -$49.6M (USD -49,617,000)
- **Total assets:** $65.5M (USD 65,469,000)
- **Cash and equivalents:** $62.4M (USD 62,431,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Net income:** -$67.1M (USD -67,112,000)
- **Total assets:** $54.4M (USD 54,397,000)
- **Cash and equivalents:** $51.6M (USD 51,557,000)
- **Operating cash flow:** -$52.7M (USD -52,668,000)
- **Later filings:** Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Net income:** -$34.4M (USD -34,439,000)
- **Total assets:** $45.8M (USD 45,753,000)
- **Cash and equivalents:** $30.7M (USD 30,688,000)
- **Operating cash flow:** -$34.7M (USD -34,736,000)
- **Later filings:** Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2016-11-01 — period 2016-11-01 — FORM 8-K
- Form SC 13D — filed 2016-09-29 — SC 13D
- Form SC 13G — filed 2016-09-23
- Form SC 13G — filed 2016-09-22 — PENTWATER CAPITAL MANAGEMENT LP SC 13G 9-20-2016 (TOBIRA THERAPEUTICS, INC)
- Form 8-K — filed 2016-09-20 — period 2016-09-19 — 8-K
- Form 10-Q — filed 2016-08-09 — period 2016-06-30 — TBRA-Q2-20160630
- Form 8-K — filed 2016-08-09 — period 2016-08-09 — Q2 2016 EARNINGS 8-K
- Form 8-K — filed 2016-07-25 — period 2016-07-25 — 8-K
- Form 10-Q — filed 2016-05-09 — period 2016-03-31 — 10-Q
- Form 8-K — filed 2016-05-09 — period 2016-05-09 — 8-K
- Form DEF 14A — filed 2016-04-28 — period 2016-06-15 — DEF 14A
- Form 8-K — filed 2016-04-11 — period 2016-04-11 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/tobira-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology